ABBOTT INDIA LIMITED
- Country
- ๐ฎ๐ณIndia
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs
- Conditions
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2012-06-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 46
- Registration Number
- NCT01084668
- Locations
- ๐ฆ๐น
Site Reference ID/Investigator# 27436, Graz, Austria
๐ฆ๐นSite Reference ID/Investigator# 27440, Vienna, Austria
๐ฆ๐นSite Reference ID/Investigator# 27435, Feldkirch, Austria
Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoing Haemodialysis
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2011-09-21
- Lead Sponsor
- Abbott
- Target Recruit Count
- 181
- Registration Number
- NCT01084538
- Locations
- ๐ญ๐ท
Site Reference ID/Investigator# 27525, Dubrovnik, Croatia
๐ญ๐ทSite Reference ID/Investigator# 27531, Imotski, Croatia
๐ญ๐ทSite Reference ID/Investigator# 6175, Karlovac, Croatia
Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs
- Conditions
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2011-08-11
- Lead Sponsor
- Abbott
- Target Recruit Count
- 162
- Registration Number
- NCT01083693
- Locations
- ๐ฆ๐น
Site Reference ID/Investigator # 32365, Linz, Austria
๐ฆ๐นSite Reference ID/Investigator # 32368, Bludenz, Austria
๐ฆ๐นSite Reference ID/Investigator # 32367, Gloggnitz, Austria
Evaluation of Kaletra Therapy Over the Long-term
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2011-08-11
- Lead Sponsor
- Abbott
- Target Recruit Count
- 284
- Registration Number
- NCT01083810
- Locations
- ๐ฉ๐ช
Site Ref # / Investigator 52972, Aachen, Germany
๐ฉ๐ชSite Reference ID/Investigator# 27629, Berlin, Germany
๐ฉ๐ชSite Reference ID/Investigator# 27562, Berlin, Germany
Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use
- Conditions
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2012-01-19
- Lead Sponsor
- Abbott
- Target Recruit Count
- 82
- Registration Number
- NCT01083160
- Locations
- ๐ฒ๐ฝ
Site Reference ID/Investigator# 27886, Guadalajara, Jal., Mexico
๐ฒ๐ฝSite Reference ID/Investigator# 27887, Guadalajara, Jal., Mexico
๐ฒ๐ฝSite Reference ID/Investigator# 27885, Mexico City,, Mexico
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer
- First Posted Date
- 2010-03-05
- Last Posted Date
- 2012-10-31
- Lead Sponsor
- Abbott
- Target Recruit Count
- 2717
- Registration Number
- NCT01081873
- Locations
- ๐ง๐ช
Site Reference ID/Investigator# 31203, Bruxelles, Belgium
๐ง๐ชSite Reference ID/Investigator# 31236, Bruxelles, Belgium
๐ง๐ชSite Reference ID/Investigator# 31200, Bruxelles, Belgium
Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary Hyperparathyroidism
- Conditions
- First Posted Date
- 2010-03-05
- Last Posted Date
- 2012-03-27
- Lead Sponsor
- Abbott
- Target Recruit Count
- 237
- Registration Number
- NCT01081665
- Locations
- ๐ฌ๐ท
Site Reference ID/Investigator# 32057, Chania, Greece
๐ฌ๐ทSite Reference ID/Investigator# 32055, Athens, Greece
๐ฌ๐ทSite Reference ID/Investigator# 32056, Chalkida, Greece
A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults
- First Posted Date
- 2010-03-05
- Last Posted Date
- 2010-10-25
- Lead Sponsor
- Abbott
- Target Recruit Count
- 24
- Registration Number
- NCT01081483
Effectiveness and Tolerability of Tarkaยฎ in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus
- Conditions
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2011-05-09
- Lead Sponsor
- Abbott
- Target Recruit Count
- 15436
- Registration Number
- NCT01079195
- Locations
- ๐ง๐ฌ
Site Reference ID/Investigator# 29681, Sofia, Bulgaria
๐ง๐ฌSite Reference ID/Investigator# 29079, Sofia, Bulgaria
๐ง๐ฌSite Reference ID/Investigator# 29484, Stara Zagora, Bulgaria
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients
- Conditions
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Abbott
- Target Recruit Count
- 7993
- Registration Number
- NCT01078584
- Locations
- ๐จ๐ฆ
Site Reference ID/Investigator# 33157, Westmount, Quebec, Canada
๐จ๐ฆSite Reference ID/Investigator# 32177, Victoria, British Columbia, Canada
๐จ๐ฆSite Reference ID/Investigator# 30945, Mississauga, Ontario, Canada